Sign Up Today and Learn More About Beacon Biosignals Stock
Invest in or calculate the value of your shares in Beacon Biosignals or other pre-IPO companies through EquityZen's platform.
Beacon Biosignals Stock
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
About Beacon Biosignals Stock
Founded
2019
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Beacon Biosignals Press Mentions
Stay in the know about the latest news on Beacon Biosignals
Beacon Biosignals partners with Harmony Biosciences to add EEG into hypersomnia Phase 3 trials
longevity • Dec 19, 2025
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
globenewswire • Dec 16, 2025
Harmony Biosciences partners with Beacon Biosignals for EEG in hypersomnia
thefly • Dec 16, 2025
Harmony Biosciences, Beacon Biosignals Collaborate on Phase 3 Trials in Narcolepsy, Hypersomnia
marketscreener • Dec 16, 2025
4 Notable Health Tech Funding Announcements in November
medcitynews • Dec 04, 2025
Beacon Biosignals Management
Leadership team at Beacon Biosignals
CEO & Co-Founder
Jacob Donoghue
CTO & Co-Founder
Jarrett Revels
Join now and verify your accreditation status to gain access to:
- Beacon Biosignals Current Valuation
- Beacon Biosignals Stock Price
- Beacon Biosignals Management
- Available deals in Beacon Biosignals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Beacon Biosignals Cap Table and Funding History by Share Class and Liquidity Preferences
- Beacon Biosignals Revenue and Financials
- Beacon Biosignals Highlights
- Beacon Biosignals Business Model
- Beacon Biosignals Risk Factors
- Beacon Biosignals Research Report from SACRA Research
Trading Beacon Biosignals Stock
How to invest in Beacon Biosignals stock?
Accredited investors can buy pre-IPO stock in companies like Beacon Biosignals through EquityZen funds. These investments are made available by existing Beacon Biosignals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Beacon Biosignals stock?
Shareholders can sell their Beacon Biosignals stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."